Indiatimes4h
Lupin shares rise 0.48% as Nifty gains
The stock quoted a 52-week high price of Rs 2312.0 and a 52-week low of Rs 1184.0. Shares of Lupin Ltd. traded 0.48 per cent ...
Pharmabiz5h
Lupin introduces bumetanide injection, USP in United States
Global pharma major Lupin Limited (Lupin) announced the launch of United Food and Drug Administration (FDA) approved bumetanide injection USP, 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL ...
Indiatimes7h
Stock market update: Nifty Pharma index 0.81% in an upbeat market
Sanofi India Ltd.(down 0.44 per cent) and Lupin Ltd.(down 0.12 per cent) were the top losers on the index. The Nifty Pharma ...
Cipla, Lupin, Delius Pharma, Sun, and Alkem Lead the Way: October Growth in India’s Generics Boom
October saw subdued growth in the Indian pharmaceutical market (IPM), with growth remaining in the low single digits, mainly ...